Skip to main content

Peer Review reports

From: CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

Original Submission
2 Apr 2019 Submitted Original manuscript
18 Apr 2019 Reviewed Reviewer Report - Chad Brenner
10 May 2019 Author responded Author comments - Christian Daniel Fankhauser
Resubmission - Version 2
10 May 2019 Submitted Manuscript version 2
13 May 2019 Reviewed Reviewer Report - Chad Brenner
10 Jul 2019 Author responded Author comments - Christian Daniel Fankhauser
Resubmission - Version 3
10 Jul 2019 Submitted Manuscript version 3
12 Jul 2019 Author responded Author comments - Christian Daniel Fankhauser
Resubmission - Version 4
12 Jul 2019 Submitted Manuscript version 4
16 Jul 2019 Author responded Author comments - Christian Daniel Fankhauser
Resubmission - Version 5
16 Jul 2019 Submitted Manuscript version 5
18 Jul 2019 Author responded Author comments - Christian Daniel Fankhauser
Resubmission - Version 6
18 Jul 2019 Submitted Manuscript version 6
Publishing
19 Jul 2019 Editorially accepted
14 Aug 2019 Article published 10.1186/s12885-019-5961-1

You can find further information about peer review here.

Back to article page